Biostem Technologies Inc
OTC:BSEM
Biostem Technologies Inc
OTC:BSEM
Price:
5.6
USD
-0.67%
Market Cap:
$94m
Relative Value
The Relative Value of one
BSEM
stock under the Base Case scenario is
27.87
USD.
Compared to the current market price of 5.6 USD,
Biostem Technologies Inc
is
Undervalued by 80%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BSEM
Relative Value
Base Case
27.87
USD
Undervaluation 80%
Multiples Across Competitors
BSEM Competitors Multiples
Biostem Technologies Inc Competitors
Biostem Technologies Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Biostem Technologies Inc
OTC:BSEM
|
94.4m USD | 0.3 | 3.6 | 2.7 | 2.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
970.2B USD | 14.9 | 47.1 | 31.7 | 33.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.3B USD | 6.4 | 22.3 | 15.5 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
288.1B CHF | 4.7 | 30.6 | 12.9 | 15.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
250B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.1B GBP | 5.4 | 31.2 | 17.3 | 24.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.1B USD | 4.6 | 16.5 | 10.2 | 12.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.3B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
